F13.9
Sedative, hypnotic or anxiolytic-related use, unspecified
Clinical Classification Guidelines
Excludes Type 1
- sedative, hypnotic or anxiolytic-related abuse (F13.1-)
- sedative, hypnotic or anxiolytic-related dependence (F13.2-)
Medical Intelligence & Overview
ICD-10 code F13.9 refers to unspecified cases involving the use of sedatives, hypnotics, or anxiolytics. These medications are commonly prescribed to manage anxiety, sleep disorders, or agitation. While they can be effective in the short term, misuse or overuse can lead to health issues, including dependence or adverse effects. This guide provides an overview of the causes, symptoms, diagnosis, and general information related to this classification.
Causes & Symptoms
Clinical Causes: Medical conditions such as anxiety, insomnia, or agitation prompting the use of sedative medications Misuse or recreational use of sedatives, hypnotics, or anxiolytics without medical supervision Development of dependence due to prolonged therapy or high doses
Key Symptoms: Drowsiness or excessive sleepiness Dizziness or lightheadedness Confusion or difficulty concentrating Impaired coordination or motor skills Respiratory depression in severe cases Signs of dependence or withdrawal upon cessation
Diagnostic & Treatment
Diagnosis Path: Diagnosis generally involves a comprehensive medical history, including details about medication use, duration, and dosage. Healthcare providers may perform physical examinations and order laboratory tests or screen for signs of overdose or dependency. Mental health assessments can help determine the extent of misuse or related psychological issues. It's important for clinicians to gather detailed information to accurately identify the cause and extent of use.
Treatment Protocols: Treatment strategies focus on managing dependence or misuse and may include supervised tapering of medications, alternative therapies such as cognitive-behavioral therapy, and addressing underlying conditions like anxiety or sleep disorders. Supportive care and monitoring are essential in cases involving overdose or adverse effects. In some circumstances, specialized programs for substance dependence may be recommended to provide structured support and treatment.
Clinical Advice & FAQs
Billing Guidance
Is F13.9 a billable ICD-10 code?
Yes, F13.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.9?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic-related use, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference